HireQuest Shares Retreat as Loan Writedown Weighs on Third-Quarter Profit

HireQuest investors are digesting a quarter in which top-line momentum and bottom-line pressure pulled in opposite directions. The staffing franchisor disclosed a third-quarter 2026 net profit of $1.7 million, down from $2.3 million a year earlier, and the stock fell sharply in the following session.

At the heart of the earnings shortfall sits a $1.3 million non-cash writedown on loan receivables, tied mainly to the repurchase of a franchise location. Because the charge never touched cash, it flattered neither the reported profit nor the headline figure investors saw — but it also says little about the day-to-day cash generation of the business.

Operating costs added their own drag. Selling, general and administrative expenses climbed 20.7% to $6.1 million. On a diluted basis, earnings per share slipped to $0.12 from $0.16 in the prior-year quarter, while adjusted net income came in at $3.0 million against $3.3 million a year earlier. Adjusted diluted earnings per share reached $0.22.

Revenue Growth Outpaces the Bottom Line

The sales picture is brighter. Quarterly revenue rose 4% year over year to $8.81 million, and on a pro-forma basis — stripping out the sale of MRINetwork — growth reached 11.1%. The two figures rest on different comparison bases.

Adjusted EBITDA held steady at $4.5 million, matching the prior-year quarter. That stability suggests the core franchise engine is still producing consistent operating earnings even as the reported profit line absorbs one-off items.

Management also pointed to improving year-over-year comparisons as the quarter progressed. By early November, weekly system-wide sales were running in the high teens percentage range above the prior year, according to media reports. HireQuest did not issue a formal revenue or earnings forecast.

For shareholders, the central question is whether those additional revenues can be converted into stronger operating profit once the writedown fades from the comparison. The steady adjusted EBITDA and the accelerating system-wide sales trend offer grounds for optimism; the higher cost base and the drop in adjusted net income counsel patience.